Scopolamine Hydrobromide
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00747 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 24 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | cauda equina syndrome | KG + DL |
| 2 | obsolete neurogenic bladder (disease) | KG + DL |
| 3 | papillary conjunctivitis | KG + DL |
| 4 | atopic conjunctivitis | KG + DL |
| 5 | rosacea conjunctivitis | KG + DL |
| 6 | vernal conjunctivitis | KG + DL |
| 7 | nasal cavity disease | KG + DL |
| 8 | acute laryngopharyngitis | KG + DL |
| 9 | idiopathic uveal effusion syndrome | KG + DL |
| 10 | idiopathic panuveitis | KG + DL |
| 11 | focal chorioretinitis | KG + DL |
| 12 | disseminated chorioretinitis | KG + DL |
| 13 | dysautonomia | KG + DL |
| 14 | pars planitis | KG + DL |
| 15 | rhinitis | KG + DL |
| 16 | large intestine disease | KG + DL |
| 17 | iritis (disease) | KG + DL |
| 18 | lens-induced iridocyclitis | KG + DL |
| 19 | glaucomatocyclitic crisis | KG + DL |
| 20 | small intestine disease | KG + DL |
| 21 | viral conjunctivitis | KG + DL |
| 22 | pityriasis simplex | KG + DL |
| 23 | allergic urticaria | KG + DL |
| 24 | food-dependent exercise-induced anaphylaxis | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.